Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

1.38

Margin Of Safety %

5

Put/Call OI Ratio

0.94

EPS Next Q Diff

-0.08

EPS Last/This Y

0.64

EPS This/Next Y

0.11

Price

46.01

Target Price

50.92

Analyst Recom

1.95

Performance Q

6.46

Relative Volume

1.37

Beta

0.36

Ticker: QGEN




20 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2024-12-19QGEN44.320.800.0012706
2024-12-20QGEN44.660.804.0011042
2024-12-23QGEN44.810.900.006460
2024-12-24QGEN45.060.922.866368
2024-12-26QGEN45.010.920.006390
2024-12-27QGEN450.921.136392
2024-12-30QGEN44.720.921.136392
2024-12-31QGEN44.540.920.006396
2025-01-02QGEN44.50.920.326399
2025-01-03QGEN44.960.9218.336405
2025-01-06QGEN44.770.940.006463
2025-01-07QGEN44.950.930.106466
2025-01-08QGEN45.260.93999.996466
2025-01-09QGEN45.260.93999.996466
2025-01-10QGEN44.690.930.026467
2025-01-13QGEN46.010.430.7110634
2025-01-14QGEN45.620.561.0010303
2025-01-15QGEN45.270.620.0011286
2025-01-16QGEN45.920.93102.008980
2025-01-17QGEN46.010.940.069060
DateSymbolLastP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2024-12-19QGEN44.329.8457.52.18
2024-12-20QGEN44.679.8458.52.18
2024-12-23QGEN44.829.8455.92.18
2024-12-24QGEN45.069.8457.02.18
2024-12-26QGEN45.019.8453.22.18
2024-12-27QGEN45.009.8453.82.18
2024-12-30QGEN44.729.8450.32.18
2024-12-31QGEN44.529.8451.42.18
2025-01-02QGEN44.499.8453.52.18
2025-01-03QGEN44.979.8459.82.18
2025-01-06QGEN44.779.8451.32.18
2025-01-07QGEN44.929.8455.72.18
2025-01-08QGEN45.269.8458.12.18
2025-01-09QGEN45.269.8453.92.18
2025-01-10QGEN44.689.8446.42.18
2025-01-13QGEN46.019.8471.42.18
2025-01-14QGEN45.609.8448.82.18
2025-01-15QGEN45.279.8450.02.18
2025-01-16QGEN45.919.8462.22.18
2025-01-17QGEN46.019.8455.32.18
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2024-12-19QGEN0.00-1.771.68
2024-12-20QGEN0.00-1.771.68
2024-12-23QGEN0.00-1.901.68
2024-12-24QGEN0.00-1.901.68
2024-12-26QGEN0.00-1.901.69
2024-12-27QGEN0.00-1.901.69
2024-12-30QGEN0.00-1.961.69
2024-12-31QGEN0.00-1.961.69
2025-01-02QGEN0.00-1.961.69
2025-01-03QGEN0.00-1.961.69
2025-01-06QGEN0.00-1.991.69
2025-01-07QGEN0.00-1.991.69
2025-01-08QGEN0.00-1.991.69
2025-01-09QGEN0.00-1.991.69
2025-01-10QGEN0.00-1.991.69
2025-01-13QGEN0.00-1.881.38
2025-01-14QGEN0.00-1.881.38
2025-01-15QGEN0.00-1.881.38
2025-01-16QGEN0.00-1.881.38
2025-01-17QGEN0.00-1.881.38
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

0.57

Avg. EPS Est. Current Quarter

0.6

Avg. EPS Est. Next Quarter

0.49

Insider Transactions

Institutional Transactions

-1.88

Beta

0.36

Average Sales Estimate Current Quarter

519

Average Sales Estimate Next Quarter

481

Fair Value

48.33

Quality Score

66

Growth Score

67

Sentiment Score

96

Actual DrawDown %

24.4

Max Drawdown 5-Year %

-37.4

Target Price

50.92

P/E

113.95

Forward P/E

20.14

PEG

18.33

P/S

5.19

P/B

2.9

P/Free Cash Flow

22.02

EPS

0.4

Average EPS Est. Cur. Y​

2.18

EPS Next Y. (Est.)

2.3

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

4.73

Relative Volume

1.37

Return on Equity vs Sector %

-16.4

Return on Equity vs Industry %

-7.7

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

455.3
Qiagen N.V.
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 5800
Qiagen N.V. offers sample to insight solutions that transform biological materials into molecular insights. The company provides sample technology consumables, such as nucleic stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, such as kits and components for purification of nucleic acids from secondary sample materials; and instruments for nucleic acid purification and accessories. It also provides interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; assays for prenatal testing and detection of sexually transmitted diseases and HPV; assays for analysis of genomic variants, such as mutations, insertions, deletions, and fusions; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. In addition, it offers PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping and gene regulation, and running on QIAGEN instruments and technologies; human ID and forensics assay consumables, such as STR assays for human ID, and assays for food contamination; PCR instruments include digital PCR and qPCR solutions; and developed and configured enzymes and PCR solutions. It also offers predefined and custom NGS gene panels, library prep kits and components, and whole genome amplification; QIAGEN consumables and instruments, as well as bioinformatics solutions; and custom laboratory and genomic services. It serves molecular diagnostics, academia, pharmaceutical, and applied testing customers. It has a collaboration with the U.S. FBI; and with Bio-Manguinhos/Fiocruz to detect malaria and dengue. The company was founded in 1984 and is headquartered in Venlo, the Netherlands.
stock quote shares QGEN – Qiagen N.V. Stock Price stock today
news today QGEN – Qiagen N.V. stock forecast ,stock prediction 2023 2024 2025
marketwatch QGEN – Qiagen N.V. yahoo finance google finance
stock history QGEN – Qiagen N.V. invest stock market
stock prices QGEN premarket after hours
ticker QGEN fair value insiders trading